MPE will hold a webinar on ASH 2018 highlights in myeloma and AL amyloidosisAL amyloidosis, Conferences, MPE, Myeloma16 January 2019
Daratumumab increases progression-free survival in newly diagnosed myeloma patients ineligible for transplantMyeloma5 December 2018
New data presented at ASH 2018 from an ongoing phase I clinical trial of CAR T cell therapy in relapsed/refractory myelomaConferences, Myeloma4 December 2018
Horizon2020 CARAMBA video on CAR-T cell therapy now available in five languagesMPE, Myeloma, Videos1 October 2018
New ESMO tumour DNA scale helps match patients with cancer to optimal targeted medicinesMyeloma21 August 2018
MPE launches Horizon2020 CARAMBA video on CAR-T cell therapy in myelomaMPE, Myeloma, Videos23 July 2018
Myeloma patient survey to inform development of personalised medicine toolMPE, Myeloma, Patient evidence26 March 2018
Myeloma Patients Europe (MPE) joins project consortium looking at the role of innovative CAR-T immunotherapy in multiple myelomaMPE, Myeloma5 March 2018
